Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 3 2Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urogenital Neoplasms 1Lung Neoplasms 1Colitis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 147pembrolizumab 124Magnetic Resonance Spectroscopy 114Cyclophosphamide 114Biopsy 104fludarabine 84Nivolumab 59Carboplatin 54Gemcitabine 46Cisplatin 46venetoclax 45Radiotherapy 45Paclitaxel 43Ipilimumab 38fludarabine phosphate 37Cetuximab 37Fluorouracil 34atezolizumab 31Bevacizumab 31durvalumab 30X-Rays 28Oxaliplatin 28Dexamethasone 28Leucovorin 27Radiation 26Irinotecan 26Azacitidine 25Injections 24Cytarabine 24Radiosurgery 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Endoscopy × 90 days × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡